The enzyme adenine phosphoribosyltransferase (APRT) functions to salvage adenine by converting it to adenosine-5-monophosphate (AMP). APRT deficiency in humans is a well characterized inborn error of metabolism, and APRT may contribute to the indispensable nutritional role of purine salvage in protozoan parasites, all of which lack de novo purine biosynthesis. We determined crystal structures for APRT from Leishmania donovani in complex with the substrate adenine, the product AMP, and sulfate and citrate ions that appear to mimic the binding of phosphate moieties. Overall, these structures are very similar to each other, although the adenine and AMP complexes show different patterns of hydrogen-bonding to the base, and the active site pocket opens slightly to accommodate the larger AMP ligand. Whereas AMP adopts a single conformation, adenine binds in two mutually exclusive orientations: one orientation providing adenine-specific hydrogen bonds and the other apparently positioning adenine for the enzymatic reaction. The core of APRT is similar to that of other phosphoribosyltransferases, although the adeninebinding domain is quite different. A C-terminal extension, unique to Leishmania APRTs, extends an extensive dimer interface by wrapping around the partner molecule. The active site involves residues from both subunits of the dimer, indicating that dimerization is essential for catalysis.
Introduction
In mammals and other organisms that can synthesize purines de novo, recycling of purines is important primarily during periods of rapid growth, such as embryogenesis and tumor proliferation (Weber et al., 1987; Pillwein et al., 1990) . The ubiquitous enzyme adenine phosphoribosyltransferase (APRT) specifically salvages adenine by catalyzing its conversion to adenosine-5-monophosphate (AMP) (Figure 1 ). Although APRT defects are not lethal in humans, they do cause 2,8-dihydroxyadenine urolithiasis (a rare form of kidney stones) (Musick, 1981; Simmonds et al., 1995) . In contrast, protozoan parasites lack a de novo biosynthetic pathway for purines and must therefore scavenge purines from their host (Berens et al., 1995) . Likewise, the importance of purine recycling for tumor cells relative to normal human cells points to APRT and other enzymes of the purine salvage pathway as potential targets for chemotherapeutic intervention.
The parasite Leishmania donovani causes visceral leishmaniasis, which is a fatal disease if untreated. Unfortunately, the treatments currently available involve highly toxic and non-selective drugs. Although APRT is not essential for purine salvage in L.donovani promastigotes (Hwang and Ullman, 1997) , the form that lives in the sandfly vector, APRT may play an essential role in the infective amastigote form of the parasite that lives in the host macrophage cells (Looker et al., 1983) . Thus, the parasite APRT is a target for anti-leishmanial chemotherapy.
Leishmania donovani APRT belongs to the family of type I phosphoribosyltransferases (PRTs) for which several three-dimensional structures are known (Table I) . PRT structures share a common core region of at least five parallel β-strands surrounded by three or more helices. The core includes a 13-residue sequence known as the α-D-5-phosphoribosyl-1-pyrophosphate (PRPP)-binding motif (Argos et al., 1983; Hershey and Taylor, 1986; Hove-Jensen et al., 1986 ) that binds the ribose ring and 5Ј-phosphate of PRPP in crystal structures of enzyme complexes with substrate or product. A flexible loop within the core sequence appears to provide a shielded environment at the active site during catalysis Schumacher et al., 1996; Krahn et al., 1997; Focia et al., 1998a; Wang et al., 1999b) . Type I PRTs also have a structurally variable region, known as the 'hood', which is responsible primarily for base recognition and the definition of substrate specificity.
Type I PRTs have been shown to bind PRPP followed by the ribose-5-phosphate acceptor (adenine in the case of APRT) (Bhatia et al., 1990; Yuan et al., 1992; Wang et al., 1999a) . Nucleophilic attack at the PRPP ribose C1Ј, which proceeds with inversion of stereochemistry, has been proposed to follow either SN1 or SN2 displacements. In an SN1 reaction, which is favored in the case of the OPRTs , an oxocarbonium intermediate would be formed before the adenine N 9 attacks the ribose C1Ј. This positively charged intermediate would require protection from solvent to prevent hydrolysis. For an SN2 reaction, as is favored in the case of Trypanosoma cruzi HGPRT (Focia et al., 1998b) , the enzyme would promote simultaneous nucleophilic attack and product formation.
Type I PRTs require a divalent metal ion, typically Mg 2ϩ or Mn 2ϩ , for activity. Most type I PRT crystal structures have identified a Mg 2ϩ or Mn 2ϩ coordinated to conserved acidic residues of the PRPP-binding motif Schumacher et al., 1996 ; Vos et al., Krahn et al. (1997) ; Muchmore et al. (1998) 1997). In PRPP-bound PRT structures, the Mg 2ϩ or Mn 2ϩ coordinates the 2Ј-and 3Ј-hydroxyls of the PRPP ribose, as well as oxygen(s) of the PRPP β-phosphate Krahn et al., 1997; Focia et al., 1998b) . In addition, a Mn 2ϩ ligand in the GAT-PRPP complex (Krahn et al., 1997 ) is coordinated by a water molecule that also hydrogen bonds with a conserved cis-peptide backbone carbonyl. Although the metal ligands are not exactly the same in each PRT structure in which a metal ion has been modeled, this metal binding site is in approximately the same region of the active site in type I PRT crystal structures. A second magnesium ion is also seen in the structure of T.cruzi HGPRT complexed with PRPP and a hypoxanthine analog (Focia et al., 1998b) . Contacts to this ion are made by the PRPP, the protein and several water molecules, one of which also hydrogen bonds with the hypoxanthine analog N 3 , suggesting a role for this metal ion in positioning the purine base for nucleophilic attack at the PRPP ribose C1Ј.
In an effort to understand further the basis for substrate selection and catalysis by APRT, we have determined the crystal structure of the enzyme from L.donovani in complexes with the substrate adenine, the product AMP and anions that mimic reactant phosphate moieties. The core region of APRT resembles that of other PRTs, although the adenine binding domain and a C-terminal extension that contributes to dimerization are unique. The APRT structure most closely resembles that of OPRT, suggesting that these enzymes share a common catalytic mechanism and constitute a subclass of type I PRTs. The L.donovani APRT structure also suggests how the structure of the considerably smaller human APRT may differ, thus guiding the design of structure-based inhibitors or 3534 subversive substrates (cytotoxic substrate analogs of adenine) targeted specifically to the L.donovani APRT.
Results and discussion

Structure determination
The crystal structure of L.donovani APRT, grown from a solution containing (NH 4 ) 2 SO 4 , was determined by the method of multiple isomorphous replacement using data collected at room temperature. This structure, apo-AS-APRT, was refined at 2.48 Å resolution to an R-factor of 17.6% (R free 25.0%). Apo-AS-APRT was used as the starting model to refine the structures of three other essentially isomorphous APRT crystals grown from solutions with PEG 5000 MME as the precipitant: unliganded APRT (apo-APRT; 1.98 Å resolution; R-factor 18.7%; R free 24.1%), APRT with bound adenine (Ade-APRT; 1.5 Å resolution; R-factor 20.0%; R free 23.9%), and APRT bound to AMP (AMP-APRT; 2.0 Å resolution; R-factor 19.6%; R free 26.3%). The use of PEG as precipitant in place of ammonium sulfate was necessary for the formation of adenine and AMP complexes. It also allowed application of low temperature methods, which provided a dramatic improvement in data quality. See Table II for  data collection statistics and Table III for heavy atom  parameters and statistics. The N-terminal methionine lacks defined density in all of the APRT structures and has not been modeled. N-terminal sequence analysis of APRT crystals revealed that this residue is absent in approximately half of the crystallized protein. Residues 120-123 are disordered and have been omitted from all the structures, although some weak density is visible in apo-APRT, Ade-APRT, and All data were used without rejection based on the estimated standard deviations. A bulk solvent correction was applied for the final map and R-factor calculations. Stereochemical criteria were defined using PROCHECK (Laskowski et al., 1993) . a R cryst ϭ Σ(||F obs |-|F calc ||)/ Σ|F obs |, crystallographic R-factor. b R free is the R-factor for a selected subset (10%) of the reflections which were not included in prior refinement calculations.
AMP-APRT. Apo-AS-APRT also lacks defined density for residue 119 and residues 236 and 237 at the C-terminus. The structures crystallized from PEG all reveal a citrate molecule (from the crystallization buffer) bound in the active site, as well as the added ligand in the Ade-APRT and AMP-APRT structures. A single magnesium ion was also found at the active site of the Ade-APRT and AMP-APRT structures. The apo-AS-APRT structure contains two sulfate ions; one in the same location as the phosphate moiety of AMP, the other in the same position as the citrate of crystals grown from PEG. Refinement statistics are given in Table IV . Fig. 2 . Definition of ligands in electron density maps. F o -F c omit electron density maps, shown in violet at 3.0σ, were calculated after simulated annealing from 1000 K and 20 rounds of positional refinement in X-PLOR (Brünger, 1996) . For clarity, the waters and magnesium ion are not shown. Refinement and phase calculations performed for: (A) the Ade-APRT model in which adenine (in orientation 'A') and citrate were omitted; (B) the Ade-APRT model in which adenine (in orientation 'B') and citrate were omitted; (C) the AMP-APRT model in which AMP and citrate were omitted; (D) the apo-AS-APRT model in which the two sulfates were omitted. These figures were made using the program O (Jones et al., 1991) .
The four structures determined are quite similar to each other. The highest resolution (1.5 Å) Ade-APRT model is used to describe general aspects of the APRT structure. Superposition of all C α carbons of Ade-APRT onto those of either the apo-APRT or AMP-APRT structures results in an average r.m.s.d. of 0.24 Å, indicating that there are no gross structural changes upon adenine or AMP binding. In addition, superposition of the C α carbons of apo-APRT and apo-AS-APRT structures also result in a low r.m.s.d. of 0.58 Å, indicating that neither freezing nor alternative (sulfate/citrate) anion coordination result in significant global structural changes in APRT. Electron density for the adenine, AMP, citrate and sulfate ligands is shown in Figure 2 .
Monomer structure
The L.donovani APRT structure ( Figure 3 ) includes nine β-strands (S1-S9) and 12 helices (H1-H12), and consists of four regions: the 'core', the 'flexible loop', the 'hood' and the C-terminal 'arm'. The APRT core, which is a conserved structure in type I PRTs, is comprised of a central β-sheet (strands S1, S2, S3, S4, S7, S8 and S9) that packs against helices H4 and H5 on one side and against H7 and H9 on the other side. The core includes a dinucleotide-binding fold, which provides the nucleotidebinding site near the C-terminal ends of the β-strands. The two β-α-β-α-β topologies of the APRT dinucleotidebinding fold are H4-S3-H5-S4 (which lacks one β-strand) and S7-H7-S8-H9-S9. As expected, the highly conserved 13-residue PRPP-binding motif, which is comprised of β-strand S7 and the following loop, adopts the same structure as seen in other type I PRTs (r.m.s.d. on C α atoms is typically Ͻ1.0 Å). The flexible loop, which is located at one end of the β-sheet, tilts away from the core rather than extending the β-sheet as it does in other PRTs. Another feature distinguishing this APRT from other PRTs is seen at the opposite end of the core β-sheet, which in APRT is extended by the two N-terminal β-strands, S1 and S2.
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The flexible loop of APRT and other type I PRTs originates in the middle of the PRT core sequence and is structurally positioned at one end of the core β-sheet. For most type I PRTs, this loop lies between the last β-strand of the dinucleotide-binding fold and an antiparallel β-strand that continues the twisted β-sheet of the core. In APRT, however, the last β-strand of the dinucleotidebinding fold (S4) is followed by a short helix (H6) and a β-ladder (S5 and S6) with the flexible loop contained between S5 and S6 and tilted away from the core (Figure 3 ).
The flexible loop apparently adopts an open conformation to allow substrate binding and a closed conformation during catalysis Schumacher et al., 1996; Wang et al., 1999b) . Indeed, structures of type I PRTs with bound PRPP reveal the loop in a closed conformation (Krahn et al., 1997; Focia et al., 1998b) , whereas in most PRT structures PRPP is not bound, and the entire flexible loop is disordered. In contrast, all four of the APRT structures lack bound PRPP, yet show this loop in a conformation that is both open and ordered, with only the very tip of the loop (residues 120-123) lacking defined density. This open and ordered conformation of the APRT loop may be defined by an interaction between the tip of the loop and Ser70 of a symmetryrelated molecule in the crystal lattice. Another possibility, that the closed conformation requires contacts to the substrate PRPP molecule, is supported by the observations that addition of PRPP slows proteolysis of the flexible loop in XPRT, and that removal of XPRT loop residues results in loss of catalytic activity without abrogating the ability to bind the product GMP (Vos et al., 1997) . The APRT loop structure may more closely resemble that observed for other PRT structures if it adopts a closed conformation during catalysis. In the open conformation, however, the loop is much further from the core β-sheet than is seen in open conformations of other type I PRTs.
The active site of type I PRTs is located between the PRT core and a structurally variable region called the 'hood' Schumacher et al., 1996 Schumacher et al., , 1998 ) that provides most of the contacts to the nucleotide base and is thus primarily responsible for the base specificity of the various PRTs. The hood of APRT is composed of helices H1, H2, H3 and the N-terminus of H4, with most of the contacts to adenine made by the loop between helices H2 and H3. The APRT hood structure does not resemble that of any other known type I PRT and bears little resemblance to a model predicted for Chinese hamster APRT (de Boer and Glickman, 1991) . Absent from the APRT hood is a contact to the adenine N 3 that is observed in all other purine/pyrimidine-binding type I PRTs and has been proposed to promote SN2-type nucleophilic attack (Focia et al., 1998b) .
The C-terminal 'arm' of L.donovani APRT is also a unique sub-structure distinct from that of other PRTs. Following the short helices H10 and H11, which project away from the core, the arm (residues 215-237) is formed by a loop and helix H12 that protrude from the monomer. Comparison of amino acid sequences indicate that this arm is unique to APRTs from Leishmania ( Figure 4) . As discussed below, the arm wraps around the partner molecule in the APRT dimer.
The APRT dimer APRT forms an extensive dimer interface about a crystallographic two-fold axis ( Figure 5A ) that buries 2670 Å 2 of the total 13 290 Å 2 solvent-accessible surface area on each monomer (Hubbard and Thornton, 1993) . Analysis by equilibrium centrifugation confirms that L.donovani APRT is a dimer in solution at pH 6.5 ( Figure 6 ). This is in contrast to a previous gel filtration study that reported L.donovani APRT to be monomeric at pH 8.0 (Allen et al., 1995) .
All of the PRTs whose structures have been determined are oligomers in solution. Remarkably, however, great variation is seen in the oligomerization geometry: OPRT is the only PRT with a dimeric interface that resembles that of APRT. Structural alignment reveals that most of the APRT and OPRT dimer cores superimpose (r.m.s.d. on 188 C α atoms is 2.9 Å, Figure 5B ). The best alignment is at the central region of the APRT dimer, which corresponds to the entire OPRT dimer interface. This common interface is comprised of contacts between symmetryrelated copies of H5 and contacts of the loop following H6 with H3 and the N-terminal two residues of H4 and H6. The superimposable dimer interfaces suggest that OPRT and APRT may represent a branch in the evolution of the type I PRT enzyme family that is distinct from the UPRTs and H/G/X/PRTs. This is consistent with the location of hood domains in the N-terminal region of APRT and OPRT, in contrast to the C-terminally located hood domains of other type I PRTs. The close structural similarity between APRT and OPRT is surprising, since type I PRT primary sequences are quite divergent and greater sequence similarity is not evident between APRT and OPRT. Unlike OPRT, the L.donovani APRT dimer interface includes contacts from the C-terminal arm, which wraps around the neighboring monomer to contact β-strand S6, helix H9, the loop following H9, and H12 of the neighboring C-terminal arm. The C-terminal arm is responsible for burying almost half (1240 Å 2 ) of the total buried (2670 Å 2 ) solvent-accessible surface area upon dimer formation. It is possible that the arm contributes to catalysis by influencing the conformation of the flexible loop, since residues 220-226 of the arm contact the S6 β-strand, which immediately follows the flexible loop in the neighboring APRT monomer. The C-terminal arm appears to be unique to APRTs from Leishmania, and may provide an advantage to the parasite by increasing catalytic efficiency compared with the host enzyme. Curiously, protruding dimerization 'arms' are a feature of at least two other PRTs, XPRT (Vos et al., 1997) and UPRT (Schumacher et al., 1998) , although these dimerization arms share neither topological nor structural similarity, nor are they peculiar to the parasite forms of the enzymes.
Ligand binding and recognition
Magnesium ion. Catalysis by APRT and the other type I PRTs requires magnesium. Type I PRT crystal structures show a Mg 2ϩ coordinated to a conserved acidic dipeptide within the PRPP-binding motif (or via water molecules to the acidic dipeptide), as well as to the ribose hydroxyls and the β-phosphate of PRPP when PRPP is bound. A single magnesium ion was located in Ade-APRT and AMP-APRT at a position close to that of a magnesium ion in other PRT crystal structures Scapin et al., 1995; Schumacher et al., 1996; Krahn et al., 1997; Vos et al., 1997; Focia et al., 1998b) . This APRT Mg 2ϩ site shows pseudo-octahedral coordination with ligands provided by the conserved side chain of Asp146 of the acidic dipeptide in the PRPP-binding motif and Thr154 O γ1 (although the Thr154 ligand is 3.7 Å distant in the AMP-APRT structure). Other ligands are provided by the ribose O3Ј of AMP (or a water molecule in Ade-APRT), a citrate hydroxyl that may mimic a contact of the substrate β-phosphate group (3.31 Å in Ade-APRT; Fig. 4 . Alignment of APRT sequences. Sequences were aligned using the program MultiAlign (Corpet, 1988) . Residue numbering refers to the L.donovani sequence. Secondary structure of L.donovani APRT is indicated above, and colored as in Figure 3 , with β-strands marked by rectangles and helices marked by ovals. Strand S1 (residues 3-7), S2 (10-13), S3 ( (228) (229) (230) (231) (232) (233) (234) (235) . The secondary structure assignments were used as defined by the program PROMOTIF (Hutchinson and Thornton, 1996) with the exceptions that helix H12 was lengthened at the C-terminus from residue 232 to 235, since this segment approximates a helical conformation, and helix H9 was shortened at the C-terminus from residue 193 to 190, since this region has an odd turn that does not appear to continue the helix smoothly. The N-terminal half of helix H5 (residues 82-88) is a 3 10 helix, as are the short helices H2, H8, H10 and H11. The remaining helices are α-helices. Conserved residues are shaded gray. Residues that contact ligands are labeled under the sequences as follows: adenine 'a'; ribose 'r'; 5Ј-phosphate 'p'; magnesium 'm'; citrate 'c'; and sulfate (at the β-phosphate position) 's'. The human, mouse and S.cerevisiae APRT mutation positions discussed in the text are indicated with colored squares: red for mutations in regions that bind the β-phosphate of PRPP, green for mutations that apparently affect the conformation of the flexible loop, blue for mutations in the regions that bind the 5Ј phosphate of PRPP. DDBJ/EMBL/GenBank database entries shown are L.donovani (409142) 2.82 Å in AMP-APRT), and a water molecule that also hydrogen bonds to the main chain carbonyl oxygen of Asp80. The backbone of Asp80 is available for this interaction as a consequence of the unusual non-proline cis-peptide bond between Asp80 and Ala81, a feature conserved at the equivalent position in other PRT structures (Escherichia coli OPRT, E.coli XPRT, Toxoplasma gondii UPRT, T.cruzi HGPRT, Tritrichomonas foetus HGXPRT and E.coli GAT). An equivalent indirect metal ligand contact by the conserved cis-peptide backbone carbonyl via a water molecule is also seen in the GAT-PRPP complex (Krahn et al., 1997) . A potential sixth magnesium ligand is the carboxylate of Glu127 in the flexible loop, which is 5 Å from the magnesium in the AMP-APRT structure but may coordinate the magnesium when the loop adopts a closed conformation.
A second magnesium ion is seen in a ternary complex of T.cruzi HGPRT with PRPP and a hypoxanthine analog (Focia et al., 1998b) . This ion coordinates an aspartate side chain of the hood as well as the hypoxanthine analog N 3 via an ordered water molecule, potentially positioning the purine base for nucleophilic attack at the PRPP ribose C1Ј. We see no evidence of a magnesium ion bound at this position in the APRT structures, nor are there any obvious acidic ligands available for coordination in this rather hydrophobic pocket of APRT.
Sulfate and citrate anions. One of the two sulfate ions Figure 3 , and the other subunit is purple. The adenine and citrate are gray with the oxygen atoms red and the nitrogen atoms blue. Adenine is shown in the 'A' orientation. The magnesium ion is green. Arg102 and Lys106 side chains are shown in ball-and-stick representation, with those belonging to the purple monomer colored dark purple, and those belonging to the multi-colored monomer in gray. (B) APRT molecules shown in dark blue and light blue, with the region that superimposes with the OPRT dimer in red and orange. The superposition was performed for the APRT dimer onto the OPRT dimer from S.typhimurium (PDB accession code 1OPR) , with equivalent residues from both monomers of the dimers included in the least squares fit. The equivalent residues, given for one monomer only, are 54-94, 95-102, 140-165, 168-174, 183-188 and 197-202 found in the apo-AS-APRT structure is in the same place as the phosphate moiety of AMP in the AMP-APRT structure (below). The other sulfate overlaps with the site occupied by a citrate ion in the apo-, Ade-and AMP-APRT structures. We speculate that this second sulfate corresponds to the binding site for the β-phosphate group of the substrate PRPP. Both of these equivalent sites are also occupied by sulfate anions in the crystal structures of E.coli OPRT (Henriksen et al., 1996) , E.coli XPRT (Vos et al., 1997) and T.gondii UPRT (Schumacher et al., 1998) . Binding of sulfates at the phosphate-binding sites explains our failure to prepare co-crystal complexes of apo-AS-APRT with substrates or products.
The citrate anion seen in apo-, Ade-and AMP-APRT ( Figures 2C, 7 and 8 ) probably mimics binding of the product pyrophosphate and the pyrophosphate moiety of the PRPP substrate. Like pyrophosphate, citrate has hydrogen bond-accepting oxygen atoms and tetrahedral coordination, although unlike pyrophosphate, citrate does not carry a highly negative charge, has protonated oxygen atoms, and is somewhat larger. The electron density for citrate was very clear in the Ade-and apo-APRT structures but rather poorly defined in AMP-APRT, where relatively high B-values (55 Å 2 ) possibly reflect partial occupancy caused by limited space for the large citrate molecule in the presence of AMP.
Contacts to the citrate include hydrogen bonds from the guanidinium N η2 of Arg82 and the backbone amides of Arg82 and cis-Ala81 (Figures 7 and 8) . Notably, Arg102 and Lys106 from the neighboring molecule in the dimer also make contact with citrate and sulfate bound at the PRPP β-phosphate position; Arg102 N η2 donates two hydrogen bonds to sulfate and citrate, while Lys106 N ζ hydrogen bonds the sulfate and is within 4 Å of the citrate. Although these residues are not conserved in hypoxanthine, guanine, xanthine or uracil PRTs, they are invariant across APRTs (Figure 4) and OPRTs, which are the only PRTs known to share the APRT dimer structure (above). The equivalent Arg and Lys residues of Salmonella typhimurium OPRT make the same contacts to the β-phosphate of bound PRPP . Furthermore, biochemical complementation studies on S.typhimurium OPRT showed that this lysine is required for catalysis in the symmetry-related active site (Ozturk al., 1995) , and a glutamine substitution at the equivalent arginine position in mouse APRT (Figures 4 and 9 ) results in lowered specific activity and slightly higher K m for PRPP (Khattar et al., 1995) . These observations strongly suggest that dimerization is required for catalysis by APRT.
It is likely that Arg102 and Lys106 function to neutralize negative charge on the β-phosphate moiety in the transition state for 5Ј-phosphoribosyl transfer. These residues are well suited to accommodate the conformational changes expected during the enzymatic reaction. Indeed, in S.typhimurium OPRT, the anomeric carbon of the ribose moiety moves 7 Å across the binding cavity in the PRPPorotate complex relative to the OMP complex . It is notable that although all type I PRTs have a common core domain and bind PRPP for 5-phosphoribosyl transfer, only APRT and OPRT have this β-phosphoryl-binding loop from a symmetry-related subunit.
AMP. The AMP-APRT structure reveals the AMP product bound in the low energy anti conformation with the ribose in the 2Ј endo conformation (Figures 7 and 8) . The hood region provides nearly all of the contacts to the adenine base, including the hydrogen bonds (Ade N η2 ···Arg41 O, and Ade N 1 ···Ala43 N), which define specificity for adenine over other purines lacking these hydrogen bonding groups. The AMP is sandwiched between the hydrophobic groups of Phe42 and Val148. Unlike other purine-and pyrimidine-binding PRTs, Val148 is the only core residue of APRT that makes direct contact with the base.
Type I PRTs that bind hypoxanthine, guanine, xanthine, or orotate select substrate, in part, on the basis of a hydrogen bond between the purine 6-oxo or pyrimidine 4-oxo group and a basic side chain just C-terminal to the fourth β-strand of the PRT core (S8 in APRT). Indeed, a mutation of this residue, Lys134Ser, enables T.foetus HGXPRT to bind adenine (Munagala and Wang, 1998) . However, consistent with the specificity for adenine, the corresponding residue in L.donovani APRT is Ile178, which cannot hydrogen bond and lies 6.0 Å distant from the adenine base in the Ade-and AMP-APRT structures. Moreover, all of the C-terminal end of APRT S8 is distant from the adenine and there are no adenine contacts from this region. Thus, in contrast to hypoxanthine, xanthine, guanine and orotate PRTs, this region of the APRT core does not contribute to base binding or specificity.
As seen in other PRT structures, the AMP phosphate and ribose groups are bound by the highly conserved PRPP-binding motif. Hydrogen bonds are made to the AMP phosphate by the backbone amides of Ala150, Thr151, Gly152, Gly153 and Thr154, and the OH groups of Thr151 and Thr154. Hydrogen bonds to the AMP ribose 2ЈOH and 3ЈOH are made by the side chains of Asp146 and Asp147, respectively. A conservative glutamate substitution for Asp147 at the equivalent position in mouse APRT (Figures 4 and 9 ) results in a dramatic loss in affinity for PRPP, and mutation to tyrosine results in a complete loss of APRT activity (Khattar et al., 1995) . This acidic residue appears to play a crucial role in PRPP binding of the ribose hydroxyls, either directly, or through the magnesium ion (see magnesium ion section above).
In HGPRTs, a Ser-Tyr dipeptide in the flexible loop is believed to be necessary for protection of the proposed oxocarbonium ion transition state, and may directly contact the PRPP ribose during the reaction (Schumacher et al., 1996; Eads et al., 1997) . Biochemical studies of mutations and chemical modifications at this dipeptide in L.donovani HGPRT result in dramatic lowering of the k cat (Jardim and Ullman, 1997) . The L.donovani APRT Glu120 and Tyr121 (Figures 4 and 9 ) in the flexible loop may play a similar role, and these residues are conserved across APRTs (Figure 4 ). Indeed mutation of the equivalent residues in Saccharomyces cerevisiae APRT (Glu106Leu and Tyr107Asp) also results in dramatically lowering the k cat for the reaction (Crother and Taylor, 1998) .
Adenine. There are two regions of local change between the Ade-APRT and AMP-APRT structures (Figure 10 ). The 5Ј-phosphate-binding loop, residues 147-154, moves by~1.0 Å to accommodate the 5Ј-phosphate of AMP, and the Arg82 guanidinium shifts by 1.4 Å to accommodate the AMP ribose.
Remarkably, the 1.5 Å resolution electron density for Ade-APRT indicated that the adenine was bound in two alternative conformations, which we have modeled as each having 50% occupancy (Figures 2A, 2B and 8) . In both orientations, adenine stacks against Phe42 and Val148, as seen for AMP-APRT. In orientation 'A', the adenine appears to be suitably positioned for the catalytic reaction, i.e. the reactive N 9 is proximal to the expected position of the PRPP ribose. Curiously, the hydrogen bonds seen in this orientation (Ade N 1 ···Arg41 O and Ade N 3 ···Ala43 O) do not explain the specificity of APRT for adenine over other purines, such as hypoxanthine, xanthine or guanine, all of which could apparently provide the equivalent hydrogen bonds with no unfavorable contacts. In contrast, orientation 'B' is not suitable for reaction with PRPP but does include hydrogen bonding contacts (Ade N 1 ···Ala43 N η and Ade N η2 ···Ala43 O) that are specific for adenine. As seen in the AMP-APRT complex, Arg82 N η2 contacts the N 3 of the adenine, but only in orientation 'B'.
Our initial expectation was that adenine alone would bind in the same manner as the adenine moiety of AMP, which seems to adopt a catalytically relevant conformation that includes base-specific hydrogen bonds. However, the electron density clearly indicates that this is not the case. Modeling of adenine into the orientation seen for AMP increases R free , and positional refinement moves the adenine into orientation 'A'. It is possible that the Ade-APRT structure is an artifact of crystallization, and that in solution the adenine may bind as observed for AMP, although the ability of AMP and adenine to bind in isomorphous crystals argues against this possibility. It is also possible that the catalytic 'A' orientation is only accessible to adenine following specific binding in the 'B' orientation, although the basis for this is not apparent from the crystal structures. Alternatively, it is possible that the specificity of APRT for adenine does not result from favorable hydrogen bonding interactions but owes more to steric limitations on positioning or reacting alternative bases in the active site. Finally, it is possible that adenine specificity derives from additional interactions formed only when the flexible loop is in the closed conformation. This idea is supported by biochemical data showing reduced adenine affinity in mouse (Khattar et al., 1995) and S.cerevisiae (Crother and Taylor, 1998) APRTs with mutations of residues equivalent to L.donovani APRT 117, 122 and 124 (Figures 4 and 9) , all of which are located at the tip of the flexible loop and could reach the adenine binding site if the loop adopts a closed conformation. There are no obvious candidates for abstracting the adenine N 9 proton when the flexible loop is in the open conformation. However, two glutamate residues in the flexible loop, Glu120 and Glu127, are completely conserved across APRTs and could reach the adenine-binding site when the loop is closed. These residues are therefore good candidates for performing proton abstraction upon loop closure.
Correlation of clinical mutations with structure
At least seven missense mutations and one codon deletion in human APRT are associated with renal dysfunction due to 2,8-dihydroxyadenine stone formation, a rare form of kidney stones (Simmonds et al., 1995) . The L.donovani APRT crystal structure explains why human APRT activity may be impaired with most of these mutations, although in most cases it is possible that the effect is more indirect, for example due to increased turnover of RNA or protein.
The mutations cluster in three regions of APRT: the regions that bind the β-phosphate of PRPP, the 5Ј phosphate of PRPP, and the region of the flexible loop proposed to close over the active site during catalysis (Figures 4 and 9) .
The Asp65Val mutation is in the region that apparently binds the PRPP β-phosphate. The carboxylate of the equivalent L.donovani Asp80 side chain hydrogen bonds the backbone N η of cis-Ala81, thereby stabilizing the conserved cis-peptide conformation that functions in coordination of the magnesium ion and the β-phosphate of PRPP. The Asp80 carboxylate also hydrogen bonds the N ε and N η2 of Arg102, a residue that makes contacts across the dimer interface to the cross-subunit β-phosphate of PRPP (citrate, sulfate in these APRT structures). Substitution of aspartate by valine at this position would result in the absence of these active site hydrogen bonds, and would probably alter PRPP binding and/or reactivity. Substitution of the adjacent residue Arg67Gln, which is equivalent to Arg82 of L.donovani, also results in APRT deficiency disease. This guanidinium hydrogen bonds to the ribose hydroxyls in the AMP-APRT structure, and substitution of this residue probably disrupts contacts to the PRPP substrate. The Arg89Gln mutation in human APRT, which is associated with renal disease and is equivalent to Ala104 in L.donovani APRT, may also disrupt the cross-subunit contacts to the PRPP β-phosphate made by nearby L.donovani Arg102 and Lys106 (Figures 4  and 9) .
The L.donovani APRT structures also suggest why human APRT function is compromised in people with a Met136Thr mutation, the most common APRT human missense mutation (Simmonds et al., 1995) . The equivalent L.donovani APRT residue, Ala155, is buried adjacent to Leu149 (Figures 7 and 8) . Human APRT Met136 presumably packs in a similarly close-packed environment, and substitution with the β-branched threonine side chain is expected to disrupt the conformation of the intervening 5Ј-phosphate binding loop of residues 150-154 in the PRPP-binding motif. Indeed, human Met136Thr APRT binds PRPP with lower affinity in a biochemical assay (Fujimori et al., 1985 (Fujimori et al., , 1986 . Likewise, the human Cys153Arg mutation (equivalent to Met172 in L.donovani APRT) probably changes the conformation of the 5Ј phosphate binding loop, since the side chain of Met172 is also buried against Ala155.
The third region of human APRT with clinically relevant mutations is the flexible loop, where the mutations Leu110Pro and Ile112Phe are associated with renal dysfunction in humans. These residues align with L.donovani APRT Pro126 and Val128. Three nearby residues (117, 122 and 124) have been implicated in adenine binding in biochemical studies on mouse (Khattar et al., 1995) and S.cerevisiae (Crother and Taylor, 1998) APRTs. The clinical effects of these mutations are not obvious from the L.donovani APRT structures, although they may disrupt the active closed conformation of the flexible loop. Deletion of human Phe173, corresponding to Arg194 in L.donovani APRT, is also associated with renal dysfunction. This residue lies at the C-terminus of helix H9, a region that is very close to the open flexible loop, and possibly stabilizes this conformation for substrate binding. Indeed, L.donovani APRT Tyr117 O η is only 3.5 Å from Thr190 C γ2 and O γ1 .
Structural differences between L.donovani APRT and human APRT may provide a basis for the development of anti-parasite therapies. The considerably smaller human APRT lacks the two N-terminal β-strands S1 and S2, as well as the C-terminal S9 strand, H10, H11 and H12 helices (Figure 4) . Therefore, the twisted β-sheet core of the human enzyme is three β-strands shorter and there is no contribution to the dimerization interface by a C-terminal arm. There also appears to be a significant difference at the active site, where non-Leishmania APRTs apparently possess a four residue insertion between Arg41 and Phe42 of L.donovani APRT. This may provide variation on the adenine binding scaffold and thereby provide an attractive basis for the development of specific therapeutic agents.
Materials and methods
Protein preparation and crystallization
Leishmania donovani APRT was purified as described (Phillips et al., 1996) , and concentrated (Gill and von Hippel, 1989) to 10 mg/ml in 10 mM MES pH 6.0, 1 mM dithiothreitol and 5 mM MgCl 2 . Crystals were grown at 4°C by vapor diffusion in 12-16 μl hanging drops comprised of equal volumes of APRT and reservoir solutions. The reservoir solution for apo-AS-APRT crystals was 1.2-1.6 M (NH 4 ) 2 SO 4 , 0.1 M sodium citrate pH 4.9 and 10 mM MgCl 2 . Prior to data collection, these crystals were equilibrated at room temperature for 1-2 h and mounted in capillaries. Apo-APRT crystals were grown at 4°C using a reservoir of 7-11% PEG 5000 monomethyl ether (MME), 0.2 M ammonium acetate, 0.1 M sodium citrate, pH 5.0, 10 mM MgCl 2 . AMPand adenine-bound APRT crystals were grown from the same conditions with either 10 mM AMP or 5 mM adenine in the reservoir solution. Crystals grown in either (NH 4 ) 2 SO 4 or in PEG 5000 MME grew to full size (typically 0.4ϫ0.4ϫ0.7 mm) within 2-4 weeks.
Data collection and processing
APRT crystals belong to space group P6 1 22, with one molecule in the asymmetric unit and a solvent content of 55% (Matthews, 1968) . Data for native and derivative apo-AS-APRT crystals were collected at room temperature on an Area Detector Systems Corporation (ADSC) multiwire detector (Xuong et al., 1985 ) with a RIGAKU RU200-H rotating anode X-ray source and processed with the software provided by ADSC. Details are described elsewhere (Phillips et al., 1996) . Data collection was performed at 100 K for the apo-, AMP-and Ade-APRT crystals grown with PEG as the precipitant. Crystals were cryoprotected by brief immersion in reservoir solution made to 20% glycerol, suspended in a rayon loop and cooled by plunging into liquid nitrogen. Cryocooling shrunk the crystals by~5 Å along the c axis, but room temperature and frozen crystals were otherwise isomorphous. Data from the AMP-and adenine-bound APRT crystals were collected at a wavelength of 1.08 Å on a MAR Research detector at beam line 7-1 of the Stanford Synchrotron Radiation Laboratory. Data from the apo-APRT crystal were collected on a Rigaku R-AXIS IV imaging plate area detector with a mirror-focused Rigaku RU-200 copper target rotating anode X-ray source operating at 5 kW. Data from cryocooled crystals were processed with the programs DENZO and SCALEPACK (Otwinowski and Minor, 1997) .
Structure determination and refinement
Crystallographic calculations employed programs from the CCP4 suite (Dodson et al., 1997 ) except where noted. The structure of apo-AS-APRT was determined by multiple isomorphous replacement methods using HgCl 2 and selenomethionine derivatives. Heavy atom sites were located by difference Patterson and Fourier synthesis, and refined using the program PHASES (Furey and Swaminathan, 1995) to give a mean figure of merit of 0.59 for data to 3.0 Å resolution (Table III) . Solvent flattening using PHASES gave a mean figure of merit of 0.85 and an electron density map into which a partial polyalanine model was built with O (Jones et al., 1991) . The map was improved by several rounds of map fitting and phase combination. Rounds of rebuilding and refinement with X-PLOR (Brünger, 1996) gave the final apo-AS-APRT model, which has an R-value of 17.6% (R free 25.0%) for all data to 2.48 Å resolution (Table IV) .
The refined apo-AS-APRT model, excluding solvent, was used as a starting model for refinement of the Ade-APRT structure. The refined structure includes an adenine, a magnesium ion and a citrate ion. The adenine could be modeled into electron density maps in two mutually exclusive overlapping orientations. No change in R free was observed following refinement using either or both adenine orientations, and both orientations are included in the final model with occupancies of 0.5. The refined structure has an R-value of 20.0% (R free 23.9%).
The adenine-APRT structure, without ligands or water molecules, was used as the starting model for refinement of the AMP-APRT and apo-APRT structures. The AMP was well defined in the [(F o -F c ), φ calc ] electron density map. The sugar pucker was unrestrained during refinement, and remained clearly in the C2Ј-endo conformation. Like Ade-APRT, both AMP-APRT and apo-APRT contain a bound citrate ion, although this is less well defined in AMP-APRT. The AMP-APRT structure has a final R-value of 19.6%, and an R free of 26.3%. The apo-APRT structure has a final R-value of 18.7%, and an R free of 24.1%. Coordinates and structure factors for all the APRT structures have been deposited with the Brookhaven Protein Data Bank (PDB accession codes: Ade-APRT, 1QB7; AMP-APRT, 1QB8; apo-APRT, 1QCC; apo-AS-APRT, 1QCD).
Equilibrium centrifugation
Equilibrium centrifugation experiments were performed using a Beckman XL-A Optima analytical centrifuge. Samples at lower protein concentrations of 0.065, 0.0325 and 0.0163 mg/ml were analyzed in 10 mM potassium phosphate pH 6.5 and scanned at 230 nm. Samples at higher protein concentrations of 0.2, 0.3 and 0.4 mg/ml were analyzed in 20 mM MES pH 6.5, 5 mM MgCl 2 and scanned at 280 nm. Samples were spun at 15 000, 18 000, 20 000, 23 000, 25 000 and 42 000 r.p.m. Scans were taken at each speed until equilibrium was reached, as judged by superimposable consecutive scans. The protein was fully sedimented at 42 000 r.p.m.. Background absorbance was corrected empirically by allowing the baseline to float during the fitting calculations, and an estimated partial specific volume of 0.73 ml/g was used to fit the data using software provided with the instrument.
